Nuclear factor E2-related factor 2 (NRF2) is encoded by the NFE2L2 gene, and the NRF2/ARE signaling pathway is considered a potential therapeutic strategy for antioxidative stress-mediated diseases, such as diabetes, fibrosis, and cancer (Thiruvengadam et al., 2021). The gene discussed is NFE2L2; the disease is cancer.